Cartesian Therapeutics, Inc.RNACNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending higher, below historical average, slight contraction.
Left:
||||
Price-to-sales ratio
Latest
11.92
↓ 88% below average
Average (9y)
95.48
Historical baseline
Range
High:806.64
Low:1.23
CAGR
-7.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 11.92 | +205.0% |
| 2023 | 3.91 | +217.7% |
| 2022 | 1.23 | -66.3% |
| 2021 | 3.65 | -76.3% |
| 2020 | 15.40 | +13.8% |
| 2019 | 13.53 | -75.4% |
| 2018 | 54.96 | -93.2% |
| 2017 | 806.64 | +4247.4% |
| 2016 | 18.55 | -25.7% |
| 2015 | 24.98 | - |